AMINOPLASMAL 25, solution pour perfusion

solution pour perfusion · intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution pour perfusion

Routeintraveineuse

Ingredient entries20

CountryFrance

Product identity

At a glance

Authorisation holder: B BRAUN MELSUNGEN
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 62947013

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for AMINOPLASMAL 25, solution pour perfusion
Ingredient	Strength / reference	Source role
ACIDE ASPARTIQUEsolution	7,95 g1000 ml de solution	SAGroup 15
ALANINEsolution	22,35 g1000 ml de solution	SAGroup 12
CYSTÉINEsolution	0,37 g1000 ml de solution	FTGroup 19
HISTIDINEsolution	5,25 g1000 ml de solution	SAGroup 11
ISOLEUCINEsolution	5,85 g1000 ml de solution	SAGroup 1
LEUCINEsolution	11,4 g1000 ml de solution	SAGroup 2
LYSINEsolution	7,95 g1000 ml de solution	FTGroup 4
PHÉNYLALANINEsolution	5,7 g1000 ml de solution	SAGroup 6
SÉRINEsolution	3 g1000 ml de solution	SAGroup 17
THRÉONINEsolution	5,4 g1000 ml de solution	SAGroup 7
TRYPTOPHANE Lsolution	2,1 g1000 ml de solution	SAGroup 8
VALINEsolution	7,2 g1000 ml de solution	SAGroup 9
ACÉTYLCYSTÉINEsolution	0,5 g1000 ml de solution	SAGroup 19
GLYCINEsolution	19,2 g1000 ml de solution	SAGroup 13
ACIDE GLUTAMIQUEsolution	16,2 g1000 ml de solution	SAGroup 16
ARGININEsolution	16,05 g1000 ml de solution	SAGroup 10
MÉTHIONINEsolution	5,7 g1000 ml de solution	SAGroup 5
PROLINEsolution	7,35 g1000 ml de solution	SAGroup 14
TYROSINEsolution	0,5 g1000 ml de solution	SAGroup 18
LYSINE MONOHYDRATÉEsolution	8,93 g1000 ml de solution	SAGroup 4

Pack references

Presentations (2)

10 flacon(s) en verre de 500 ml

CIP13 3400927941801

Présentation active · Déclaration d'arrêt de commercialisation

6 flacon(s) en verre de 1000 ml

CIP13 3400927942051

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 62947013 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →